CLINUVEL PHARMACEUTICALS LIMITED 
By ABN | Quarter ended ("current quarter") | |
88 089 644 119 | 31 DEC 2011 |
Cash flows related to operating activities |
Current quarter | Year to date (6 months) $A'000 | |
1.1 | Receipts from customers | 462 | 825 |
1.2 | Payments for (a) staff costs (b) advertising and marketing (c) research and development (d) leased assets (e) other working capital | (1,407) (85) (1,382) (47) (481) | (2,942) (114) (2,957) (104) (902) |
1.3 | Dividends received | ||
1.4 | Interest and other items of a similar nature received | 165 | 398 |
1.5 | Interest and other costs of finance paid | (7) | (17) |
1.6 | Income taxes paid | - | - |
1.7 | Other (incl GST, FBT refunds) | 42 | 84 |
Net operating cash flows | (2,740) | (5,729) | |
Current quarter $A'000 | Year to date ( 6 months) $A'000 | ||
1.8 | Net operating cash flows (carried forward) | (2,740) | (5,729) |
Cash flows related to investing activities | |||
1.9 | Payment for acquisition of: (a) businesses (item 5) (b) equity investments - financial instruments ** (see bottom of page) (c) intellectual property (d) physical non-current assets (e) other non-current assets | - - - - - | - - - - - |
1.10 | Proceeds from disposal of: (a) businesses (item 5) (b) equity investments - financial instruments ** (c) intellectual property (d) physical non-current assets (e) other non-current assets | - 215 - - - | - 2,376 - - - |
1.11 | Loans to other entities | - | - |
1.12 | Loans repaid by other entities | - | - |
1.13 | Other (provide details if material) | - | - |
Net investing cash flows | 215 | 2,376 | |
1.14 | Total operating and investing cash flows | (2,525) | (3,353) |
Cash flows related to financing activities | |||
1.15 | Proceeds from issues of shares, options, etc. | - | - |
1.16 | Proceeds from sale of forfeited shares | - | - |
1.17 | Proceeds from borrowings | - | - |
1.18 | Repayment of borrowings | - | - |
1.19 | Dividends paid | - | - |
1.20 | Other (Capital Raising Costs) | - | - |
Net financing cash flows | - | - | |
Net increase (decrease) in cash held | (2,525) | (3,353) | |
1.21 | Cash at beginning of quarter/year to date | 11,468 | 12,178 |
1.22 | Exchange rate adjustments | (133) | (15) |
1.23 | Cash at end of quarter (see below) | 8,810 | 8,810 |
** Payment for acquisition of, and proceeds from equity investments represents cash flows into financial instruments. These instruments do not meet the strict definition of a cash equivalent within AASB107 Cash Flow Statements, and are defined by the Standard to be financial assets held for trading, hence do not form part of Cash at end of quarter. As at 31st December 2011, the Cash at Bank and Investments in financial instruments total $11,752k.
Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the related entities
Current quarter | ||
1.24 | Aggregate amount of payments to the parties included in item 1.2 | 726 |
1.25 | Aggregate amount of loans to the parties included in item 1.11 | n/a |
1.26 | Explanation necessary for an understanding of the transactions | |
Director's fees including payment of STI
Bonus to CEO | ||
2.1 | Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows |
2.2 | Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest |
Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2).
Amount available $A'000 | Amount used $A'000 | ||
3.1 | Loan facilities | n/a | n/a |
3.2 | Credit standby arrangements | n/a | n/a |
Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows. | Current quarter $A'000 | Previous quarter $A'000 | |
4.1 | Cash on hand and at bank | 2,748 | 4,403 |
4.2 | Deposits | 6,000 | 7,000 |
4.3 | Bank overdraft | 0 | 0 |
4.4 | Other (Security Deposits) | 62 | 65 |
Total: cash at end of quarter (item 1.23) * | 8,810 | 11,468 | |
As at 31st December 2011, the Cash at Bank and Investments in long term financial instruments total $11,752k.
Acquisitions and disposals of business entitiesAcquisitions (Item 1.9(a)) | Disposals (Item 1.10(a)) | ||
5.1 | Name of entity | n/a | n/a |
5.2 | Place of incorporation or registration | ||
5.3 | Consideration for acquisition or disposal | ||
5.4 | Total net assets | ||
5.5 | Nature of business | ||
